Instrumento Inactivo

Otros idiomas Alexza Pharmaceuticals, Inc. Nasdaq

Acciones

US0153841004

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Alexza Pharmaceuticals : Reports Fourth Quarter and Year End 2015 Financial Results	28/03/16
Alexza Pharmaceuticals : to Report 2015 Year End Financial Results and Provide Company Update on Monday, March 28, 2016	15/03/16
Alexza Pharmaceuticals : Receives Positive Nasdaq Listing Determination	09/03/16
Alexza Pharmaceuticals : Confirms Grupo Ferrer Non-binding Letter of Intent	27/02/16
Alexza Pharmaceuticals : Reacquires U.S. Commercial Rights for ADASUVE® (loxapine) inhalation powder	24/02/16
Alexza Pharmaceuticals : Les valeurs à suivre sur les marchés américains	22/12/15
Alexza Pharmaceuticals : Amends Autoliv Agreement for Heat Packages Used in ADASUVE®	16/12/14
Alexza Pharmaceuticals : Diario Medico Names ADASUVE® in its "Best Ideas of 2014"	11/12/14
Alexza Pharmaceuticals : Announces the Launch of ADASUVE® (inhalation powder, loxapine) in Guatemala	08/08/14
Alexza Pharmaceuticals : and Ferrer Announce the Launch of ADASUVE® (inhalation powder, loxapine) in Romania	13/03/14
Alexza Pharmaceuticals, Inc. : Alexza Announces the U.S. Commercial Launch of ADASUVE® by Teva Pharmaceuticals	03/03/14
Alexza Pharmaceuticals, Inc. : Alexza Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference	21/11/13
Alexza Pharmaceuticals, Inc. : Alexza Reports 2013 Third Quarter Financial Results	06/11/13
Alexza Pharmaceuticals, Inc. : Alexza Pharmaceuticals and Grupo Ferrer Announce the Launch of ADASUVE® (Staccato® Loxapine) in Austria	24/10/13
Alexza Pharmaceuticals, Inc. : Alexza to Report 2013 Third Quarter Financial Results on Wednesday, November 6, 2013	16/10/13
Alexza Pharmaceuticals, Inc. : Alexza Pharmaceuticals to Present at the Stifel Healthcare Conference 2013	29/08/13
Alexza Pharmaceuticals, Inc. : Alexza Reports Preliminary 2013 Second Quarter Financial Results	09/08/13
Alexza Pharmaceuticals, Inc. : Alexza Pharmaceuticals to Present at the 2013 Wedbush Life Sciences Management Access Conference	07/08/13
Alexza Pharmaceuticals, Inc. : Alexza Announces Management Promotions	01/08/13
Alexza Pharmaceuticals, Inc. : Alexza Pharmaceuticals Announces European Launch of ADASUVE® (Staccato® Loxapine)	30/07/13

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Alexza Pharmaceuticals, Inc. Nasdaq

Acciones

US0153841004

Otros idiomas

Filtros